KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Intangibles (2016 - 2022)

Novavax has reported Intangibles over the past 10 years, most recently at $8.5 million for Q3 2022.

  • Quarterly results put Intangibles at $8.5 million for Q3 2022, up 68.21% from a year ago — trailing twelve months through Sep 2022 was $8.5 million (up 68.21% YoY), and the annual figure for FY2021 was $4.8 million, down 16.68%.
  • Intangibles for Q3 2022 was $8.5 million at Novavax, up from $4.0 million in the prior quarter.
  • Over the last five years, Intangibles for NVAX hit a ceiling of $8.5 million in Q3 2022 and a floor of $4.0 million in Q2 2022.
  • Median Intangibles over the past 5 years was $5.5 million (2019), compared with a mean of $5.8 million.
  • Biggest five-year swings in Intangibles: fell 27.21% in 2018 and later skyrocketed 68.21% in 2022.
  • Novavax's Intangibles stood at $6.5 million in 2018, then fell by 14.68% to $5.6 million in 2019, then grew by 2.58% to $5.7 million in 2020, then decreased by 16.68% to $4.8 million in 2021, then surged by 77.27% to $8.5 million in 2022.
  • The last three reported values for Intangibles were $8.5 million (Q3 2022), $4.0 million (Q2 2022), and $4.5 million (Q1 2022) per Business Quant data.